Table 3.
Percentage of responses in agreement (strongly or somewhat agree) with statements about the use of direct-to-consumer (DTC) genetic testing, physician preparedness, and patient interest (n = 130).
| Attitude | Pre-Testing (Somewhat/Strongly Agree) n = 130 |
Post-testing (Somewhat/Strongly Agree) n = 130 |
McNemar Test of Independence (p-Value) |
|---|---|---|---|
| I understand the limitations, risks and benefits of using DTC testing services | 43.9% | 83.7% | <0.01 |
| I have enough knowledge to help patients understand the results of DTC genetic tests | 26.9% | 73.1% | <0.01 |
| I feel confident about discussing DTC genetic testing with my patients. | 20.0% | 70.7% | <0.01 |
| Most physicians have sufficient knowledge to help patients understand the results of DTC genetic tests | 12.3% | 46.9% | <0.01 |
| If a patient of mine inquired about DTC testing, I would likely recommend that they consider it. | 33.8% | 62.3% | <0.01 |
| Most of my patients could understand their DTC genetic test results. | 9.3% | 37.5% | <0.01 |
| DTC genetic testing will likely play an important role in my practice | 31.0% | 30.0% | p = 1.0 |
| Some of my patients would be interested in DTC genetic testing | 86.0% | 84.5% | 0.81 |